You are here

Cempra

Cempra announces positive results of intravenous solithromycin

Yahoo/Fly on the Wall

Mon, 10/8/12 - 10:47 am

Cempra Inc.'s Solithromycin (CEM-101) Demonstrates In Vitro Activity Against Antibiotic-Resistant Neisseria Gonorrhoeae Isolates

Yahoo/PR NewsWire

Sat, 03/31/12 - 11:58 am

2 Life Sciences IPOs Debut Below Target

Seeking Alpha

Sun, 02/5/12 - 12:15 pm

Greenway Medical Technologies

Antibiotics developer Cempra braves tough market with $86M IPO

Fierce Biotech

Thu, 10/13/11 - 01:32 pm

Cempra Pharmaceuticals Presents New Data on TAKSTA(TM) (CEM-102, sodium fusidate) at the 50th IntersConference on Antimicrobial Agents and Chemotherapy (ICAAC)

PR-USA.net

Sun, 09/12/10 - 11:43 am

infectious diseases

Optimer Pharmaceuticals gets $500,000 payment

Yahoo/AP

Thu, 07/8/10 - 11:37 am

Pages